Inventor
KIM RONALD M
US28 patents
⚠️ This page may combine multiple inventors who share the name “KIM RONALD M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
14 patentsUS7687534B2Mar 30, 2010
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
MERCK SHARP & DOHME26 citations91
US10011595B2Jul 3, 2018
Ethyldiamine orexin receptor antagonists
MERCK SHARP & DOHME7 citations84
US9938276B2Apr 10, 2018
6,5-bicyclic octahydropyrrolopyridine orexin receptor antagonists
MERCK SHARP & DOHME2 citations73
US9718828B2Aug 1, 2017
BTK Inhibitors
MERCK SHARP & DOHME7 citations71
US10519147B2Dec 31, 2019
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels
MERCK SHARP & DOHME1 citations61
US10221167B2Mar 5, 2019
Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channels
MERCK SHARP & DOHME1 citations61
US7968589B2Jun 28, 2011
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
MERCK SHARP & DOHME4 citations61
US7989472B2Aug 2, 2011
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
MERCK SHARP & DOHME3 citations60
US7935713B2May 3, 2011
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
MERCK SHARP & DOHME2 citations59
US10968210B2Apr 6, 2021
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels
MERCK SHARP & DOHME0 citations51
US9481682B2Nov 1, 2016
Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitors
MERCK SHARP & DOHME2 citations51
US9637486B2May 2, 2017
Btk inhibitors
MERCK SHARP & DOHME0 citations49
US9446130B2Sep 20, 2016
BTK inhibitors
MERCK SHARP & DOHME1 citations48
US9834554B2Dec 5, 2017
BTK inhibitors
MERCK SHARP & DOHME0 citations38
MERCK & CO INC
7 patentsUS5877214AMar 2, 1999
Polyaryl-poly(ethylene glycol) supports for solution-phase combinatorial synthesis
MERCK & CO INC56 citations96
US6511994B2Jan 28, 2003
Modulators of CCR5 chemokine receptor activity
MERCK & CO INC24 citations92
US7301036B2Nov 27, 2007
Cyclic guanidines, compositions containing such compounds and methods of use
MERCK & CO INC45 citations88
US6498161B1Dec 24, 2002
Pyrrolidine modulators of chemokine receptor activity
MERCK & CO INC12 citations73
US7598398B2Oct 6, 2009
Acyl indoles, compositions containing such compounds and methods of use
MERCK & CO INC2 citations61
US7563815B2Jul 21, 2009
Benzamidazoles, compositions containing such compounds and methods of use
MERCK & CO INC2 citations49
US6132953AOct 17, 2000
Combinatorial synthesis on soluble polyvalent supports having a discrete architecture
MERCK & CO INC0 citations46
MERCK SHARP & DOHME LLC
2 patentsUS11884683B2Jan 30, 2024
Tricyclic heterocycle compounds useful as HIV integrase inhibitors
MERCK SHARP & DOHME LLC4 citations72
US12246008B2Mar 11, 2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels
MERCK SHARP & DOHME LLC0 citations51